Can mean platelet volume serve as a marker for prostatitis?

Area of Science:

• Urology
• Inflammation markers
• Prostate health

Background:

• Prostatitis is a common condition affecting men.
• Current markers for prostatitis assessment include prostate-specific antigen (PSA) levels.
• The role of inflammation markers in prostatitis requires further investigation.

Purpose of the Study:

• To compare mean platelet volume (MPV), total prostate-specific antigen (tPSA), free prostate-specific antigen (fPSA), f/t PSA ratio, and complex prostate-specific antigen (cPSA) in prostatitis patients.
• To evaluate the correlation between these markers and the extent/aggressiveness of prostatic inflammation.
• To determine if MPV can be used as an inflammation marker in prostatitis.

Main Methods:

• Retrospective study of 96 prostatitis patients at Kayseri Education and Research Hospital.
• Laboratory data including tPSA, fPSA, f/t PSA ratio, cPSA, and MPV were analyzed.
• Histopathological grading of inflammation extent and aggressiveness using the Irani et al. system.

Main Results:

• No significant differences in tPSA, fPSA, f/t PSA ratio, cPSA, or pre/post-treatment MPV values were observed between groups (p>0.05).
• No correlation was found between histopathological grades and MPV, tPSA, fPSA, f/t PSA ratio, or cPSA.
• MPV values significantly decreased after treatment across all prostatitis grades (p<0.001).

Conclusions:

• Mean platelet volume (MPV) may serve as a valuable inflammation marker in prostatitis.
• The decrease in MPV post-treatment indicates its potential for monitoring inflammatory response.
• Further research is warranted to establish MPV as a standard biomarker for prostatitis.